Keynote Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Buy |
872
+245
| +39% | +$129K | 0.31% | 88 |
|
|
2025
Q1 | $398K | Buy |
627
+88
| +16% | +$55.8K | 0.28% | 97 |
|
|
2024
Q4 | $384K | Buy |
539
+41
| +8% | +$29.2K | 0.29% | 97 |
|
|
2024
Q3 | $524K | Sell |
498
-18
| -3% | -$18.9K | 0.4% | 72 |
|
|
2024
Q2 | $542K | Buy |
516
+16
| +3% | +$16.8K | 0.45% | 62 |
|
|
2024
Q1 | $481K | Buy |
+500
| New | +$481K | 0.4% | 72 |
|